Legend Biotech Corp ADR (LEGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 286,749 | 1,277,713 | 786,031 | 688,938 | 455,689 |
| Marketable Securities | 836,004 | 31,361 | 240,889 | 194,901 | 50,384 |
| Receivables | 6,287 | 100,041 | 90 | 50,410 | 74,978 |
| Inventories | 23,903 | 19,433 | 10,354 | 1,749 | 1,800 |
| TOTAL | $1,283,918 | $1,497,799 | $1,099,119 | $949,850 | $592,858 |
| Non-Current Assets | |||||
| PPE Net | 99,288 | 108,725 | 105,168 | 102,506 | 113,091 |
| Investments And Advances | 374 | 451 | 914 | 2,168 | 224 |
| Intangibles | 2,160 | 4,061 | 3,409 | 4,684 | 2,852 |
| Other Non-Current Assets | 284,414 | 237,573 | 122,353 | 60,257 | 11,982 |
| TOTAL | $386,236 | $350,810 | $231,844 | $169,615 | $128,149 |
| Total Assets | $1,670,154 | $1,848,609 | $1,330,963 | $1,119,465 | $721,007 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 204,774 | 152,962 | 217,002 | 130,601 | 104,406 |
| Other current liabilities | 47,406 | 53,078 | 67,451 | 88,204 | 55,297 |
| TOTAL | $277,645 | $216,418 | $297,788 | $229,204 | $161,167 |
| Non-Current Liabilities | |||||
| Long Term Debt | 301,196 | 281,328 | 260,932 | 120,462 | N/A |
| Other Non-Current Liabilities | 50,767 | 99,492 | 27,931 | 3,855 | 279,585 |
| TOTAL | $351,963 | $380,820 | $288,863 | $124,317 | $279,585 |
| Total Liabilities | $629,608 | $597,238 | $586,651 | $353,521 | $440,752 |
| Shareholders' Equity | |||||
| Common Shares | 37 | 36 | 33 | 31 | 27 |
| Retained earnings | 1,040,509 | 1,251,335 | 744,279 | 765,913 | 280,228 |
| TOTAL | $1,040,546 | $1,251,371 | $744,312 | $765,944 | $280,255 |
| Total Liabilities And Equity | $1,670,154 | $1,848,609 | $1,330,963 | $1,119,465 | $721,007 |